IL1B and depressive disorder: Injection of interleukin-1β (IL-1β) receptor antagonist in the CNS ventricular space reduced the depressive behavior and KMO mRNA levels, but did not change the allodynia, revealing the role of IL-1β in depression but not in the pain mechanism [53].